Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is one of the best small-cap biotech stocks to buy according to analysts. Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025. The quarter marked continued advancement of its muscular dystrophy and cardiac programs. Meanwhile, its critical GRAND CANYON cohort for sevasemten in Becker muscular dystrophy remains well-positioned for readout in Q4 2026. At t ...